Provectus Pharmaceuticals pharmaceuticals news

Provectus spun out its Pure-ific Corp. subsidiary after raising "sufficient funds" for the move in a related unit offering. Pure-ific will have OTC products Pure-ific and Pure-ific Kids quick-drying sprays, which Provectus said immediately kill 99.9% of germs on skin and prevent re-growth for six hours. As part of the offering, investors received a unit comprising a share and a warrant to purchase 0.75 shares. Provectus first disclosed its plans to spin off its non-core assets in its FY10 10-K. The company plans to pursue the spin off of its remaining four "non-core" subsidiaries - Provectus Biotech Inc., Provectus Devicetech Inc., Provectus Imaging Inc. and Xantech Pharmaceuticals Inc. - through a subsequent unit offering. ...